United States· US:69918-515_2b581a09-38d8-4bd7-8b0a-17fa460b90f8
neomycin sulfate, polymyxin b sulfate and dexamethasone
A medicinal product containing neomycin sulfate; polymyxin b sulfate; dexamethasone, registered in United States by Nordic Pharma, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- NEOMYCIN SULFATE; POLYMYXIN B SULFATE; DEXAMETHASONE
- Manufacturer
- Nordic Pharma, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1169918515055 mL in 1 BOTTLE, PLASTIC (69918-515-05)
- ndc1169918-515-05
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Neomycin sulfate; polymyxin b sulfate; dexamethasone in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaMAXITROLNovartis s.r.o., Praha
- GermanyIsopto-MaxNovartis Pharma Gmbh
- FinlandMaxitrolNovartis Finland Oy
- IrelandMaxitrol 0.1% w/v, 6000 IU/ml, 3500 IU/ml eye drops, suspensionNovartis Ireland Limited
- NorwayMaxitrolNOVARTIS NORGE AS
Authorised across Europe · EMA
The same active substance is authorised in 19 EEA countries. Names it is sold under:
- Belgium · Maxitrol
- Bulgaria · Макситрол, Неладекс
- Cyprus · Isopto Maxitrol
- Czechia · Maxitrol
- Germany · Isopto-Max
- Estonia · Maxitrol
- Spain · Maxitrol
- France · Maxidrol
- United Kingdom (Northern Ireland) · Maxitrol
- Croatia · Maxitrol
- Ireland · Maxitrol
- Iceland · Maxitrol
- Lithuania · Maxitrol
- Luxembourg · Maxitrol
- Latvia · Maxitrol
- Norway · Maxitrol
- Poland · Maxitrol
- Romania · Maxitrol
- Slovenia · Maxitrol
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bcc357c3-62dc-4b52-b8c5-74c443892ece GET /v1/drugs/bcc357c3-62dc-4b52-b8c5-74c443892ece?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "OPHTHALMIC",
"source": "ndc",
"strength": "3.5; 10000; 1",
"substance": "NEOMYCIN SULFATE; POLYMYXIN B SULFATE; DEXAMETHASONE",
"productndc": "69918-515",
"dosage_form": "SUSPENSION",
"dea_schedule": null,
"strength_unit": "mg/mL; [USP'U]/mL; mg/mL",
"application_number": "NDA050023",
"marketing_category": "NDA AUTHORIZED GENERIC"
}See everything about neomycin sulfate; polymyxin b sulfate; dexamethasone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.